Survivin Long Peptide Vaccine in Treating Patients With Metastatic Neuroendocrine Tumors

Conditions:   Lung Atypical Carcinoid Tumor;   Lung Typical Carcinoid Tumor;   Metastatic Digestive System Neuroendocrine Neoplasm;   Metastatic Lung Neuroendocrine Neoplasm;   Metastatic Pancreatic Neuroendocrine Tumor;   Survivin Positive Interventions:   Biological: Incomplete Freund's Adjuvant;   Drug: Octreotide Acetate;   Biological: Sargramostim;   Biological: SVN53-67/M57-KLH Peptide Vaccine Sponsors:   Roswell Park Cancer Institute;   NeuroEndocrine Tumor Research Foundation (NETRF);   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials